14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Wednesday, 24th Apr 2024 ALNY stock ended at $143.80. This is 1.55% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.76% from a day low at $143.52 to a day high of $147.49.
90 days $143.51 $188.69
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jan 12, 2021 $156.03 $165.91 $156.03 $165.65 1 550 933
Jan 11, 2021 $148.56 $157.39 $146.42 $156.63 1 306 350
Jan 08, 2021 $138.73 $147.00 $137.72 $146.66 807 931
Jan 07, 2021 $133.62 $140.00 $132.03 $139.40 1 072 128
Jan 06, 2021 $126.33 $128.13 $125.38 $126.83 758 132
Jan 05, 2021 $125.56 $127.70 $124.00 $127.45 496 517
Jan 04, 2021 $130.69 $132.78 $126.94 $128.10 527 407
Dec 31, 2020 $131.33 $132.42 $127.69 $129.97 338 669
Dec 30, 2020 $131.90 $134.16 $129.17 $131.04 256 897
Dec 29, 2020 $134.56 $136.91 $130.00 $130.56 366 185
Dec 28, 2020 $138.60 $140.00 $133.67 $134.08 337 788
Dec 24, 2020 $138.62 $140.11 $136.80 $137.56 150 982
Dec 23, 2020 $138.30 $140.01 $135.47 $138.62 587 102
Dec 22, 2020 $139.44 $142.35 $137.57 $138.31 559 582
Dec 21, 2020 $137.12 $140.79 $136.83 $139.43 485 524
Dec 18, 2020 $140.00 $142.61 $136.88 $142.39 1 225 821
Dec 17, 2020 $139.93 $139.93 $136.42 $138.65 577 554
Dec 16, 2020 $136.05 $139.49 $134.71 $138.32 577 945
Dec 15, 2020 $134.07 $136.64 $133.08 $135.70 417 885
Dec 14, 2020 $131.63 $135.37 $131.01 $132.69 529 258
Dec 11, 2020 $126.42 $130.40 $126.26 $129.65 493 437
Dec 10, 2020 $124.04 $127.30 $123.47 $126.05 349 811
Dec 09, 2020 $127.51 $127.59 $121.98 $124.04 530 425
Dec 08, 2020 $127.07 $128.21 $125.35 $128.05 346 271
Dec 07, 2020 $129.74 $130.67 $126.00 $126.81 300 881
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT